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DIVERSE WAYS TO THINK ABOUT CANCER
What can we learn about cancer by studying it across the tree of life?
E. Yagmur ErtEn and Hanna KoKKo
When asked about cancer, most would first think of it as a devastating disease. Some might add 
that lifestyle (e.g., smoking) or environmental pollution has something to do with it, but also that it 
tends to occur in old people. Cancer is indeed one of the most common causes of death in humans, 
and its incidence increases with age. Yet, focusing on our own species, we tend to overlook 
something very elementary: cancer is not unique to humans. In fact, it is a phenomenon that unifies 
diverse branches of the tree of life. Exploring the diversity of ways in which different organisms 
cope with it can lend us novel insights on cancer. In turn, by acknowledging cancer as a selective 
pressure, we can better understand the evolution of the biodiversity that surrounds us.
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 ■ WHAT IS CANCER?
A skin cell will never meet a liver cell, but they 
come from the same fertilized egg and work together 
to ensure that the body functions well. Unless a cell 
is specially geared towards reproduction, it will 
die when the organism does so. What then makes 
it work so hard? An answer is the shared interest 
in the fate of shared genes, and organisms have 
various ways to ensure the cooperation between their 
cells (reviewed in Aktipis et al., 2015). However, 
occasionally some cells escape these control 
mechanisms: if a cell divides 
faster than its neighbour in the 
short term it is, from a numerical 
perspective, at an advantage. 
Cancer is the uncontrollable 
division and spread of these cells 
within an organism. 
At a molecular level, cancer 
results from the accumulation of mutations in the 
lineage of cells on their way from the fertilized egg to 
a tissue: a cell stops listening to the rules dictating 
when it should divide and when not. Because the 
«anti-cancer» mechanisms are themselves genetically 
encoded, mutations that disrupt the functioning 
of these genes can initiate cancer. Mutations are not 
rare: the DNA in our cells tend not to be fully 
identical copies of what was there at fertilization. If a 
mutation occurs in a key cancer-related gene, cells 
can become malignant. Taking colorectal cancer as an 
example, the process might start with a mutation 
in a tumour-suppressor gene (e.g., APC gene), 
which results in the uncontrolled growth of the cells 
into a mass (Vogelstein et al., 2013). Subsequent 
mutations in other key genes (e.g., KRAS or TP53) 
can allow cells to divide faster, let this mass grow 
larger, and eventually invade the surrounding tissue 
as well as distant parts of the body (Vogelstein et al., 
2013). Although the genes involved differ between 
cancer types and organisms, as well as within 
one single tumour itself, the problem is a general 
one: keeping the genetic 
content of all cells unchanged 
across numerous cell divisions 
is impossibly difficult. 
We would therefore expect 
all multicellular organisms to be 
susceptible to cancer.
This expectation 
is confirmed: cancer is widespread across the tree 
of life. Within the animal kingdom, essentially 
all vertebrates can get cancer (Aktipis et al., 2015). 
If we expand the definition of cancer to include 
any uncontrollable growth and cover the tumours 
that do not spread (i.e., metastasize), cancer-like 
phenomena are almost ubiquitous. From invertebrates 
like famous Drosophila flies to more simple animals 
like hydra, cancer tends to be found once we care 
to look for it (Aktipis et al., 2015). Even plants cannot 
«Cancer is an underappreciated 
factor in natural selection and 
evolution»
Monjalés. The tree of life, 2019. From the «Thalesian certifications» series. Oil on Fabriano Rosaspina paper, 200 g, 33 × 46 cm.
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escape it, though the plant way of keeping cells inside 
cell walls, without circulating blood, limits the spread 
of any one tumour. 
We believe that cancer is an underappreciated 
factor in natural selection and evolution. Cancer 
in the wild might remain undetected. If, for example, 
a sparrowhawk attacks a flock of feeding birds, 
being the slowest of the flock to take off is bad news 
for survival. If one bird is not in prime condition 
(due to the initial stages of cancer), it will become 
a sparrowhawk’s breakfast. In this case, one might 
simply categorize the cause of death as predation, 
but what natural selection actually ended up doing 
here was to remove genes that made an individual 
prone to getting cancer. This problem makes it hard 
to collect data to compare cancer incidences across 
wild species. Zoos are therefore valuable sources 
of cancer data: since animals in captivity are not 
exposed to predation and may also have a reduced 
parasite burden, their intrinsic cancer proneness 
is easier to measure, fuelling the burgeoning field 
of comparative oncology (e.g., Abegglen et al., 2015).
 ■ PETO’S PARADOX: WHO EXCELS AT CANCER 
AVOIDANCE?
Comparing cancer incidences across species results 
in some counter-intuitive insights: large-bodied 
and long-lived animals are not as cancer prone as we 
would expect. Before explaining why, let us consider 
why one would expect cancer risk to increase with 
body size and lifespan in the first place. Take a step 
back and, again, consider cancer as an outcome 
of multicellularity. Multicellular organisms start from 
a single cell and require cell divisions to reach their 
«target» body size. Once fully grown, one might think 
dividing could stop, but no: cell divisions are still 
needed, with the reasons ranging from wound healing 
to the gut’s inability to distinguish between food 
and its own lining when digesting organic material. 
Each cell division comes with a risk of a cancer-
inducing mutation happening, and if this remains 
undetected, it will be passed on to all descendants 
of this cell. Purely by chance, we would therefore 
expect a larger number of cells to translate into 
a higher probability of dangerous mutations 
per animal. Likewise, long-lived animals would have 
more time to accumulate these mutations.
Cancer data from humans support this expectation: 
being 10 cm taller increases one’s cancer risk 
by about 10% (Nunney, 2018). This is a modest 
change in body size, if we consider the full extent 
of body size variation within animals. In fact, 
extrapolating from this, one could argue humans, 
having 1,000 times the size and 30 times the lifespan 
of mice, should routinely succumb to cancer (Peto, 
1977) and elephants and whales should be so cancer-
prone that they should not even reach reproductive 
age. But… they do, an observation known as «Peto’s 
Paradox». To be precise, the paradox refers to a lack 
of increase of cancer incidence with lifespan and body 
size across species (Abegglen et al., 2015). This lack 
of correlation has far-reaching implications: large 
and long-lived animals must have evolved ways 
to combat an a priori higher cancer risk.
 ■  WHAT CAN OTHER SPECIES TEACH US 
ABOUT CANCER SUPPRESSION?
Intrigued by Peto’s Paradox, researchers have set out 
to explore the relative cancer-robustness of large-
sized and long-lived animals. Although one cannot 
easily argue for replacing lab rats and mice with 
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populations of lab whales, gentler 
methods of genomic analyses have 
led to the discovery of possible 
mechanisms these animals 
might have evolved on their 
way to a «large» life. Elephants, 
for example, have 19 extra copies 
of TP53 gene, which is a crucial tumour suppressor 
gene that coordinates various DNA damage responses 
from halting cell division to programmed cell death 
(Abegglen et al., 2015). Experiments hint that 
these extra copies really do help: when treated with 
DNA damaging agents, elephant cells had a higher 
rate of programmed cell death (so-called apoptosis) 
compared to human cells (Abegglen et al., 2015). 
In other words, elephant tissues might be «more alert» 
than humans’ when it comes to judging the health 
of their cells; elephant bodies kill their damaged cells 
faster, recycling the material as food for other cells, 
rather than letting a potentially dangerous cell lineage 
participate in the future of the tissue. 
Naked mole rats provide another curious case 
of cancer evasion. Their strikingly long lifespan (up 
to 32 years in captivity) with extremely low cancer 
incidence (six known cases) has long puzzled ageing 
and cancer researchers (Seluanov, Gladyshev, Vijg, 
& Gorbunova, 2018). Or so until a team working 
on naked mole rat cells noticed an important clue: 
naked mole rat cells divided very slowly in the 
laboratory conditions (Seluanov et al., 2018). Normal 
cells in a tissue stop dividing when they reach a given 
density. This mechanism, called «contact inhibition», 
is employed by multicellular organisms to keep cell 
divisions under control. Losing contact inhibition 
is one of the characteristics of cancer cells, allowing 
them to continue dividing even when they reach high 
density. Naked mole rat cells secrete a unique molecule 
that increases their sensitivity to contact inhibition 
(Seluanov et al., 2018) – one of the mechanisms 
they might be employing against cancer. Another 
way naked mole rats keep their cells under check 
is via increased sensitivity to DNA damage: their cells 
go through programmed cell death upon losing only 
one of the tumour suppressors (specifically: p53, RB, 
or p19ARF), while the same loss results in an increased 
cell division in humans or mice (Seluanov et al., 2018). 
A variety of genomic changes, such as copy number 
variations in cancer-related genes (as described 
above for elephants), have become established 
in long-lived and/or large-sized animals, including 
e.g., bats and whales (Tollis, Schiffman, & Boddy, 
2017). Comparing genetic 
sequences and the functions 
of those genes have already 
led to the discoveries 
of cancer risk management 
in elephants and naked mole 
rats, and therefore highlight 
promising research avenues that 
might nourish clinical cancer 
research as well. The study of cancer across species 
offers intuition about where to look; the beauty of this 
research program is that it begins with an appreciation 
of features of life that have existed since 
multicellularity first arose, then scans observations 
that do not match expectations (a similar incidence 
of cancer across species of varying size and lifespan) 
to pinpoint species that could be particularly 
interesting (large ones like whales, or outliers who live 
longer than expected based on body size alone, such 
as bats).
 ■ CAN CANCER AFFECT THE EVOLUTION 
OF BIOLOGICAL DIVERSITY?
Even a superficial look at nature reveals that 
species vary in size and, as highlighted above, this 
has implications for cell division management. 
Size differences do not only matter for cancer risk 
and tumour suppression mechanisms; body size 
is actually a key trait that influences many aspects 
of species’ ecology and evolution. For instance, larger 
«Body size is actually a key 
trait that influences many 
aspects of species’ ecology 
and evolution»
Cancer-like phenomena are observed across the diversity of life. 
Plants may be better than animals in coping with the uncontrolled 
growth of their cells, as a result of their cell walls and modularity. 
Due to this, they stand to prove pervasiveness of cancer-like 
phenomena, as seen here in these specimens of saguaro (left) 
and daisy (right), both with an abnormal growth (also known 
as fasciation in plants). 
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animals typically live longer, while smaller animals 
tend to reproduce earlier and have more offspring. 
Within a species, being larger than one’s conspecifics 
tends to yield a competitive edge, and species indeed 
tend to evolve towards larger body sizes over time 
– the so-called Cope’s rule (Kingsolver & Pfennig, 
2004). Why some species remain small is therefore 
a conundrum of evolutionary biology (Blanckenhorn, 
2000). One inevitably wonders whether cancer risk 
can prevent lineages from increasing in size, if they 
aren’t lucky enough to have acquired the elephant-
like innovations discussed above.
Evidence from various large-sized organisms 
suggests that adaptations to an increased cancer risk 
could be a prerequisite for a larger body size. Using 
a mathematical model, Kokko and Hochberg (2015) 
showed that an increase in body size can translate 
into a reduction in lifespan due to cancer. However, 
the organism may still enjoy a net benefit if the other 
advantages of being large sufficiently compensate 
such costs (e.g., a large animal 
of either sex might outgrow some 
of its predators, or a big male 
might win fights over access 
to mating opportunities with 
females), or, of course, if cancer 
suppression is adequately 
elevated. Some support for the 
latter comes from a recent study, 
which reported that a gene 
involved in cell death response 
(LIF6) in elephants appears to have evolved around 
the same time as this lineage increased in body 
size (Vazquez, Sulak, Chigurupati, & Lynch, 2018). 
The authors suggest that this adaptation might 
have been «permissive» for body size evolution 
in the elephant lineage (Vazquez et al., 2018). Even 
when increased cancer suppression is theoretically 
achievable, if an organism has a high probability 
of dying due to extrinsic causes it may not live long 
enough to benefit significantly from its improved 
cancer defences (Kokko & Hochberg, 2015). 
Accordingly, both the cancer risk and the ecological 
context need to be factored in when studying 
the evolution of biological diversity.
 ■ CAN ORGANISMS ADAPT TO A CHANGING 
CANCER RISK?
While the evolution of cancer suppression mechanisms 
allows species to become larger and live longer, 
organisms may also experience changes in cancer 
risk compared with their ancestors (Hochberg & 
Noble, 2017). Humans are a 
prime example of this. We enjoy 
a longer average lifespan than 
our ancestors, largely thanks 
to a better control of infectious 
diseases and improved diets. 
We are also larger, though with 
much interpopulation variation. 
If the circumstances that 
prevailed during much of our 
evolutionary past differ from the current ones, there 
may be a mismatch between how long our genes 
«expect» our bodies to live for and how long they 
can do so now (Brown, Cunningham, & Gatenby, 
2015; Hochberg & Noble, 2017). As a result, modern 
humans might lag behind their currently optimal 
levels of cancer suppression (Brown et al., 2015). This, 
of course, does not mean that we cannot do anything 
about it. Healthy lifestyles can reduce cancer risk, 
and research into treatments has greatly improved 
survival odds once a tumour is discovered (Brown 
et al., 2015; Hochberg & Noble, 2017). 
Zooming out from ourselves, humans are not 
the only species suffering from such a mismatch: 
human-mediated environmental changes can increase 
cancer risk for all the populations exposed to them 
(Giraudeau, Sepp, Ujvari, Ewald, & Thomas, 2018; 
Hochberg & Noble, 2017). From various sources 
of pollution (e.g., toxic industrial waste, light 
and noise pollution) to diet-associated changes (e.g., 
human food waste that potentially has carcinogenic 
toxins), wild organisms face novel cancer-related 
«In humans, there may be 
a mismatch between how long 
our genes “expect” our bodies 
to live for and how long they 
can do so now»
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pressures due to human activity (Giraudeau 
et al., 2018). Obviously, cancer is not the sole 
problem of flora and fauna trying to survive 
the Anthropocene; it might not even be in the top 
ten. Yet, the fact that evolutionary adaptations tend 
to happen more slowly than ecological changes 
suggests that an increasing cancer risk could 
become a conservation issue. 
 ■ A FEATHERY END 
Most ecological and macroevolutionary «rules» 
are there to be broken, and Cope’s rule is no 
exception. Not every lineage evolves towards larger 
sizes. Dinosaurs were immensely large, but not 
all of them; some actually became miniaturized after 
having spent some evolutionary time in the mid-size 
range (for a dinosaur). This theropod lineage also 
survived the meteoritic event that killed off the large 
ones; the descendants of these survivors are the 
birds that fly, hop and sing on our planet today 
(Lee, Cau, Naish, & Dyke, 2014). Do modern birds 
show traces of their dinosaurian past, with anti-
cancer adaptations still there from their large-bodied 
history? Data suggest that birds might be more 
cancer-robust compared to mammals (Effron, 
Griner, & Benirschke, 1977). This opens the doors 
for many exciting questions like whether birds 
can have different cancer suppression mechanisms 
compared to those already found in mammals, 
further highlighting the importance of the diverse 
ways to think about cancer. 
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Each cell division comes with a risk of a cancer-inducing 
mutation happening. This should mean that a larger 
number of cells involves a higher probability of dangerous 
mutations per animal, especially if they are long-lived 
animals. However, species like elephants (both large 
and with a long lifespan) or naked mole rats (which 
can live up to 32 years in captivity) seem to have evolved 
cell risk management strategies that translate into a really 
low cancer incidence.
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